News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Markets mostly unchanged as no major headlines emerged in the past hour.
  • US equities traded with low volatility and light volume across sectors.
  • Treasury yields moved little, reflecting muted risk sentiment and no fresh economic data.
  • Dollar held steady against majors amid absence of new monetary guidance.
  • Oil and commodities showed minimal movement without supply or demand shocks.
  • No significant geopolitical or corporate announcements were reported in the last hour.

Latest Articles

Stereotaxis Announces Definitive Agreement to Acquire Robocath

Stereotaxis Announces Definitive Agreement to Acquire Robocath

Stereotaxis, a NYSE-listed leader in surgical robotics, entered into a definitive agreement to acquire Robocath, a French innovator in robotic technologies for interventional cardiology and neurointerventions. The acquisition aims to combine complementary robotic technologies to provide an integrated platform for a broad range of endovascular proce…

Dime Announces Appointment of Meyer Eichler as Executive Vice President, Managing Executive Director

Dime Announces Appointment of Meyer Eichler as Executive Vice President, Managing Executive Director

Dime Community Bancshares, a New York-based bank holding company, announced the appointment of Meyer Eichler as Executive Vice President and Managing Executive Director. Eichler will focus on expanding Dime's presence within the Orthodox Jewish community in New York and New Jersey, targeting key sectors such as healthcare, real estate, retail, whol…

Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression

Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression

Medicus Pharma announced new Phase 1 clinical data for Teverelix, its investigational long-acting GnRH antagonist, demonstrating predictable estradiol suppression, favorable pharmacokinetics for infrequent dosing, and good safety profile. The findings support advancing Teverelix development for hormone-driven conditions including endometriosis and …

Bitdeer Announces March 2026 Production and Operations Update

Bitdeer Announces March 2026 Production and Operations Update

Bitdeer Technologies Group announced significant operational growth in March 2026, including a 480% year-over-year increase in Bitcoin production to 661 BTC and a 105% month-over-month rise in AI cloud annual recurring revenue to approximately $43 million. The company is expanding its AI and Bitcoin mining infrastructure, advancing new colocation d…

TG Therapeutics Announces Completion of Enrollment for the Phase 3 Trial Evaluating Subcutaneous BRIUMVI

TG Therapeutics Announces Completion of Enrollment for the Phase 3 Trial Evaluating Subcutaneous BRIUMVI

TG Therapeutics announced the completion of enrollment for its Phase 3 trial testing subcutaneous delivery of BRIUMVI, an anti-CD20 monoclonal antibody for relapsing multiple sclerosis (RMS). The study compares two dosing regimens administered subcutaneously to the existing intravenous formulation, aiming to demonstrate non-inferiority in drug expo…

Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B

Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B

Arbutus Biopharma announced that the U.S. FDA has granted Fast Track designation for their RNAi therapeutic imdusiran targeting chronic hepatitis B. This designation may accelerate the drug’s review and development, offering potential benefits such as earlier FDA interactions and expedited approval pathways. Clinical trials showed promising results…

Plus Therapeutics Appoints Randy H. Goodman, PhD, MHA, as Vice President of Value Strategy & HEOR to Advance Market Access and Commercial Execution

Plus Therapeutics Appoints Randy H. Goodman, PhD, MHA, as Vice President of Value Strategy & HEOR to Advance Market Access and Commercial Execution

Plus Therapeutics, a clinical-stage healthcare company specializing in precision diagnostics and radiopharmaceuticals for CNS cancers, has appointed Randy H. Goodman, PhD, MHA, as Vice President of Value Strategy & HEOR. Goodman brings over 20 years of experience in health economics, market access, and payer engagement, expected to fortify Plus The…

Alterity Therapeutics to Host Virtual KOL Event to Share New Insights on ATH434 for the Treatment of Multiple System Atrophy

Alterity Therapeutics to Host Virtual KOL Event to Share New Insights on ATH434 for the Treatment of Multiple System Atrophy

Alterity Therapeutics announced a virtual event featuring key opinion leaders to discuss insights on their lead drug candidate ATH434 for Multiple System Atrophy (MSA). The company will review Phase 2 clinical trial results demonstrating clinical efficacy and provide a high-level overview of the planned Phase 3 pivotal trial. The event aims to info…

Monarch Casino & Resort, Inc. Slot Machine Change Program Surpasses $1 Million in Charitable Donations

Monarch Casino & Resort, Inc. Slot Machine Change Program Surpasses $1 Million in Charitable Donations

Monarch Casino & Resort, Inc. announced that its slot machine change donation program at Atlantis Casino Resort Spa in Reno and Monarch Casino Resort Spa Black Hawk has exceeded $1 million in contributions to various charities. Powered by IGT technology, the program allows guests to easily donate their remaining slot machine change to nonprofit org…

Traws Pharma Announces Up to $60 Million Private Placement Financing

Traws Pharma Announces Up to $60 Million Private Placement Financing

Traws Pharma announced a private placement financing expected to raise approximately $10 million in gross proceeds initially, with potential additional proceeds up to $50 million through milestone-based and three-year warrants. The financing will support the completion of a human challenge trial for its influenza treatment tivoxavir marboxil in the…

Union Bankshares Announces Earnings for the three months ended March 31, 2026 and Declares Quarterly Dividend

Union Bankshares Announces Earnings for the three months ended March 31, 2026 and Declares Quarterly Dividend

Union Bankshares, Inc. announced a net income increase to $3.0 million ($0.65 per share) for Q1 2026, driven by growth in net interest income and strong asset management. The bank's total assets rose by 6.6% year-over-year to $1.63 billion, with strategic investment securities growth. The company declared a $0.36 per share quarterly dividend, refle…

60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website

60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website

60 Degrees Pharmaceuticals announced that its FDA-approved malaria prevention drug ARAKODA (tafenoquine) is now available for purchase through the Runway Health telehealth platform, enabling U.S. travelers to conveniently obtain prescriptions and receive medication delivered prior to traveling to malaria-endemic regions. The once-weekly dosing regi…

Capital Clean Energy Carriers Corp. Divests 49% Stake in LNG Carrier ("LNG/C") Amore Mio I, Forms a Joint Venture Company With an Affiliate of the BGN Group and Secures 10-Year Time Charter

Capital Clean Energy Carriers Corp. Divests 49% Stake in LNG Carrier ("LNG/C") Amore Mio I, Forms a Joint Venture Company With an Affiliate of the BGN Group and Secures 10-Year Time Charter

Capital Clean Energy Carriers Corp. has agreed to sell a 49% stake in its LNG carrier Amore Mio I to an affiliate of BGN Group via a new joint venture. The joint venture secured a 10-year time charter agreement with BGN INT DMCC, expected to generate revenues up to $485.6 million, enhancing the company's charter portfolio, financial flexibility, an…

Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products

Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products

Mesoblast Limited has secured an exclusive worldwide license to innovative chimeric antigen receptor (CAR) technology developed at Mayo Clinic to genetically engineer its mesenchymal stromal cell (MSC) products. The integration aims to significantly improve targeted homing, immunomodulation, and tissue regeneration capabilities of Mesoblast’s FDA-a…

Toll Brothers Announces Final Opportunity for Luxury Living at Santa Rosa Valley Estates in California

Toll Brothers Announces Final Opportunity for Luxury Living at Santa Rosa Valley Estates in California

Toll Brothers, a leading US luxury home builder, announced the last homes available in its Santa Rosa Valley Estates gated community in California. The community features spacious, high-end homes with modern designs, large lot sizes, and optional multigenerational suites, with prices starting from $3.18 million. This marks the final opportunity for…

One Stop Systems CEO and Chairman Issue Letter to Shareholders

One Stop Systems CEO and Chairman Issue Letter to Shareholders

One Stop Systems, Inc. reported record quarterly earnings per share and gross margins for 2025, with revenue growth of 31.2% and a strengthened strategic focus on rugged Enterprise Class compute solutions for AI and sensor processing at the edge. The company highlighted expanding defense contracts, including the P-8 Poseidon program, and growth in …

Sprott Launches Rare Earths Ex-China ETF

Sprott Launches Rare Earths Ex-China ETF

Sprott Inc. announced the launch of the Sprott Rare Earths Ex-China ETF (Nasdaq: REXC), the only ETF offering focused exposure to rare earth companies operating outside of China. This ETF addresses the strategic importance of diversifying rare earth element supply chains critical for advanced technology sectors like defense, AI, EVs, and semiconduc…

Picard Medical / SynCardia Highlights Total Artificial Heart Bridge to Transplant Case at Texas Children's Hospital

Picard Medical / SynCardia Highlights Total Artificial Heart Bridge to Transplant Case at Texas Children's Hospital

Picard Medical, trading on NYSE American as PMI, highlighted the successful use of its SynCardia Total Artificial Heart (STAH) as a life-saving bridge to transplant at Texas Children's Hospital for a 21-year-old patient undergoing a complex heart re-transplant. This case underscores the critical role and flexibility of the STAH in managing advanced…

TeraWulf Announces Pricing of Upsized Common Stock Offering

TeraWulf Announces Pricing of Upsized Common Stock Offering

TeraWulf Inc. priced an upsized public common stock offering of 47.4 million shares at $19.00 per share, raising gross proceeds of about $900 million. The offering aims to fund construction of a new data center campus in Kentucky, repay bridge credit facility obligations, and support future site acquisitions and corporate purposes. The transaction …